Treating Multiple Sclerosis in 2013
DOCTORS DISCUSS EVERY MS TREATMENT NOW AVAILABLE INCLUDING:
(1) Alemtuzumab (marketed as Campath and currently under further development as LEMTRADA)(2) teriflunomide (AUBAGIO)
(3) dimethyl fumarate (TECFIDERA)
(4) FINGOLIMOD
(5) TYSABRI (natalizumab)
